Female adnexal tumor of probable wolffian origin: A clinicopathological case report and a possible new treatment

International Journal of Gynecological Cancer

Volumn 14, Issue 3, 2004, Pages 546-550

  Steed, Helen ^a,d   Oza, A ^b   Chapman, W B ^c   Yaron, M ^a   De Petrillo, D ^a  

^a Division of Gynecologic Oncology   (Canada)

^b Department of Medical Oncology ^*  (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

FATWO; Gleevac; Wolffian

Indexed keywords

AMIFOSTINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IFOSFAMIDE; IMATINIB; PROTEIN TYROSINE KINASE; STEM CELL FACTOR RECEPTOR;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FEMALE; FEMALE ADNEXAL TUMOR OF PROBABLE WOLFFIAN ORIGIN; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LAPAROTOMY; MESONEPHROMA; METASTASIS; NEUTROPENIA; PELVIS; POSTOPERATIVE PERIOD; PRESCRIPTION; PRIORITY JOURNAL; RETROPERITONEAL CANCER; SIDE EFFECT; TREATMENT OUTCOME; TUMOR NECROSIS;

ABDOMINAL PAIN; ADOLESCENT; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; ENZYME INHIBITORS; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; PERITONEAL NEOPLASMS; PROTEIN-TYROSINE KINASES; WOLFFIAN DUCT;

EID: 2942566195     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1048-891x.2004.014319.x     Document Type: Article

References (18)

1. Kariminejad MH, Scully RE. Female adnexal tumor of probable Wolffian origin. Cancer 1973;31:671-7.
2. Rahilly MA, Williams ARW, Krausz T, Al Nafussi A. Female adnexal tumour of probable wolffian origin: a clinicopathological and immunohistochemical study of three cases. Histopathology 1995;26:69-74.
3. Flanagan AM, Kane JL, Norman-Taylor JQ. Female adnexal tumour of probable wolffian origin. Case report. Br J Obstet Gynaecol 1987;94:270-2.
4. Young RH, Scully RE. Ovarian tumors of probable wolffian origin: a report of 11 cases. Am J Surg Pathol 1983;7:125-35.
5. Devouassouz-Shisheboran M, Silver SA, Tavassoli FA. Wolffian adnexal tumor, so-called female adnexal tumor of probable wolffian origin (FATWO): immunohistochemical evidence in support of a wolffian origin. Hum Pathol 1999;30:856-63.
6. Ramirez PT, Wolf JK, Malpica A, Deavers MT, Liu J, Broaddus R. Wolffian duct tumors: case reports and review of the literature. Gynecol Oncol 2002;86:225-30.
7. Brescia RJ, Cardosa de Almeida PC, Fuller AF, Dickersin GR, Robboy SJ. Female adnexal tumor of probable wolffian origin with multiple recurrences over 16 years. Cancer 1985;56:1456-61.
8. Taxy JB, Battifora H. Female adnexal tumor of probable wolffian origin: evidence for a low-grade malignancy. Cancer 1976;37:2349-54.
9. Prasad CJ, Ray JA, Kessler S. Female adnexal tumor of wolffian origin. Arch Pathol Lab Med 1992;116:189-91.
10. Demopoulos RI, Sitelman A, Flotte T, Bigelow B. Ultra-structural study of a female adnexal tumor of probable wolffian origin. Cancer 1980;46:2273-80.
11. Delaloye JF, Ruzicka J, De Grandi P. An ovarian tumor of probable wolffian origin. Acta Obstet Gynecol Scand 1993;72:314-6.
12. Hughesdon PE. Ovarian tumors of wolffian or allied nature: their place in ovarian oncology. J Clin Pathol 1982;35:526-35.
13. Sivathondan Y, Salm R, Hughesdon PE, Faccini JM. Female adnexal tumor of probable wolffian origin. J Clin Pathol 1979;32:616-24.
14. Daya D, Murphy J, Simon G. Paravaginal female adnexal tumor of probable wolffian origin. Am J Clin Pathol 1994;101:275-8.
15. Hinchey WW, Silva EG, Guarda LA, Ordonex NG, Wharton JT. Paravaginal wolffian duct (mesonephros) adenocarcinoma: a light and electron microscopic study. Am J Clin Pathol 1983;80:539-44.
16. Abbot RL, Barlogie B, Schmidt WA. Metastasizing malignant juxtaovarian tumor with terminal hypercalcemia: a case report. Cancer 1981;48:860-5.
17. Sheyn I, Mira JL, Bejarano PA, Husseinzadeh N. Metastatic female adnexal tumor of probable wolffian origin: a case report and review of the literature. Arch Pathol Lab Med 2000;124:431-4.
18. Demetri GD, von Mehren M, Blanke CD et al. Efficacy and safety of Imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472-80.